These presentations will only be displayed if you allow third-party cookies.
More about this in our privacy policy .
Presenter / Co-Authors: Timon Ax (1,4), Detlev Breyer (1,4), Hakan Kaymak (1,4), Karsten Klabe (1,4), Philipp Hagen(1,4), Florian Kretz (2,4), Gerd Auffarth (3,4)
Affiliations: (1) Breyer, Kaymak & Klabe Augenchirurgie, (2) Dr. Gerl & Kollegen Ahaus-Raesfeld-Rheine, (3) Universitaets-Augenklinik Heidelberg, (4) International Vision Correction Research Center (IVCRC.net)
Purpose:
Former studies showed comparable visual recovery after ReLEx SMILE and Femto-LASIK. For LASIK, however, there is evidence that PTA (Percent Tissue Altered) values >40% can be seen as a contributing factor in the development of keratectasia. This retrospective analysis addresses the question whether this also holds for increased PTA values in case of ReLEx SMILE.
Setting/Venue:
All ReLEx SMILE (VisuMax, CZM) surgeries were performed at the Breyer, Kaymak & Klabe Eyesurgery in Duesseldorf, Germany, which is part of the International Vision Correction Research Center (IVCRC.net).
Methods:
We analyzed the impact of high PTA-values by comparing the results of 2 ReLEx SMILE groups; 350 eyes with PTA<40% and 350 eyes with PTA>40%. Follow up was performed between 1 day and up to 5 years postoperatively. Visual outcome was evaluated in terms of visual acuity and manifest refraction. Development of ectasia was assessed using a combined analysis of corneal Scheimpflug tomography data (Belin-Ambrosio Enhanced Ectasia Display, Pentacam, Oculus) and deformation response parameters from a non-contact tonometer (Corvis, Oculus). Among others, we compared the values for R_min, BAD-D and TBI as well as the recently developed biomechanical parameter CBI.
Results:
Overall PTA values ranged from 29% to 53%. We could not detect significant differences between the two PTA-groups (<40% and >40%) in terms of visual acuity and manifest refraction. Both groups showed a mean monocular UDVA of <0.05 LogMAR one year after treatment. Furthermore, the postoperative progression of the values for R_min, BAD-D, TBI and CBI were similar in both groups with and no significant differences could be found.
Conclusions:
For ReLEx SMILE with PTA above 40% our analysis of tomographic and biomechanical indices did not provide evidence for keratectasia development. Further studies with longer follow-up time and larger number of patients will be needed to confirm these first findings.